ADVERTISEMENT

Another peer reviewed study touting ivermectin

TRACKEM

First Round Draft Pick
Gold Member
Jun 24, 2001
24,173
16,932
113
NEW - Peer-reviewed, large PSM study from Brazil finds, "regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization, and mortality rates."

Cureus Journal of Medical Science today:
 
  • Like
Reactions: Eagle
ADVERTISEMENT
ADVERTISEMENT

Go Big.
Get Premium.

Join Rivals to access this premium section.

  • Say your piece in exclusive fan communities.
  • Unlock Premium news from the largest network of experts.
  • Dominate with stats, athlete data, Rivals250 rankings, and more.
Log in or subscribe today Go Back